References
- Ayer DE, Kretzner L and Eisenman RN, Mad:a heterodimeric partner for Max that antagonizes Myc transcrip-tional activity, Cell 1993; 72: 211 -222 https://doi.org/10.1016/0092-8674(93)90661-9
- Counter CM, Avilion AA, LeFeuvre CE, Stewart NG,Greider CW, Harley CB and Bachetti S. Telomere shor-tening associated with chromosome instability is arres-ted in immortal cells which express telomerase activity, EMBO J.1992; 11: 1921-1929
- Counter CM, Hirte HW, Bachetti S and Harley CB. Telo-merase activity in human ovarian carcinoma, Proc. Natl. Acad. Sci. 1994; 91: 2900-2904 https://doi.org/10.1073/pnas.91.8.2900
- Greeberg RA, O'Hangan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB and DePi-nho RA. Telomerase reverse transcriptase gene is a dir-ect target of c-Myc but is not functionally equivalent in cellular transformation, 1999; Oncogene 18: 1219-1226 https://doi.org/10.1038/sj.onc.1202669
- Greider CW. Chromosome first aid, Cell 1991; 67: 645-647 https://doi.org/10.1016/0092-8674(91)90058-7
- Greider CW. Telomerase activation. One step on the road to cancer? Trends Genet, 1999; 15: 109-112 https://doi.org/10.1016/S0168-9525(98)01681-3
- Hanahan D and Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70 https://doi.org/10.1016/S0092-8674(00)81683-9
- Harley CB, Futcher AB and Greider CW. Teloineres shorten during ageing of human fibroblasts, Nature (Lond.) 1990; 345: 458-460 https://doi.org/10.1038/345458a0
- Hyman T, Rothmann C, Heller A, Malik, Z and Salzberg S. Structural characterization of erythroid and megakaryocytic differentiation in Rriend erythroleukemia cells, Exp. Hematol. 2001; 29: 563-571 https://doi.org/10.1016/S0301-472X(01)00616-6
- Kim NW, Piatyszek MA, Prowse KR, Karley CB, West MD, Ho PL, Coviello GM, Wrisht WE, Weinrich SL and Shay JW. Specific association of human telomerase activity with immortal cells and cencer, Science (Wash-inton DC) 1994; 266: 2011 -2015 https://doi.org/10.1126/science.7605428
- Kroemer G, Dallaporta B and Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis, Annu. Rev. Physiol. 1998; 60: 619-642 https://doi.org/10.1146/annurev.physiol.60.1.619
- Liu JR, Chen BQ, Yang YM, Wang XL, Xue YB, Zheng YM and Liu RH. Effect of apoptosis in gastric adenocarcinoma cell line SGC-7901 induced by cis-9, trnas-11-conjugated linoleic acid. World J, Gastroenterol. 2002; 8: 999-1004 https://doi.org/10.3748/wjg.v8.i6.999
- Marks PA, Richon VM, Kiyokawa H and Rifkind RA. Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process, Proc. Natl. Acad. Sci. USA, 1994; 91: 10251-10254 https://doi.org/10.1073/pnas.91.22.10251
- Michaeli J, Rifkind RA and Marks PA. Differentiating agents in cancer therapy, Cancer Chemother. Biol. Response Modifiers 1992; 13: 287-307
- Ruefli AA, Smyth, MJ and Johnstone RW. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediate multidrug reso-stance, Blood 2000; 95: 2378-2385
- Schreiber-Agus N and DePinho RA. Repression by the Mad(Mxi1)-Sin3 complex, Bioessays 1998; 20: 808-818 https://doi.org/10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U
- Shay JW and Bacchetti S. Telomerase activity in human cancer, Eur J. Cancer 1997; 33: 787-791 https://doi.org/10.1016/S0959-8049(97)00062-2
- Shelly LL, Fuchs C and Miele L. Notch-1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds, J. Cell Biochem.1999; 73: 164-175 https://doi.org/10.1002/(SICI)1097-4644(19990501)73:2<164::AID-JCB3>3.0.CO;2-0
- Siegel DS, Zhang X, Feinman R, Teitz T, Zelentz A, Richon VM, Rifkind RA, Marks PA and Michaeli J. Hexame thylene bisacetamide induces programmed cell death (apoptosis) and dowm-regulates BCL-2 expression in human myeloma cells, Proc. Natl. Acad. Sci. 1998; 95: 162-166 https://doi.org/10.1073/pnas.95.1.162
- Van Steensel B, Smogorzewska A and de Lange T. TRF2 protects human telomeres from end-to-end fusions, Cell 1998; 92: 401-413 https://doi.org/10.1016/S0092-8674(00)80932-0
- Wang J, Xie LY, Allan S, Beach D and Hannon GJ. Myc activates telonerase, Genes Dev. 1998; 12: 1769-1774 https://doi.org/10.1101/gad.12.12.1769
- Watson JD. Origin of concatemeric T7 DNA, Nature (Lond) 1972; 239: 197-201 https://doi.org/10.1038/239197a0
- Williams GT. Programmed cell death: apoptosis and oncogenesis, Cell 1991; 65: 1097-1098 https://doi.org/10.1016/0092-8674(91)90002-G
- Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Ploack A, Lingner J and Dalla-Favera R. Direct activation of TERT transcription by c-MYC, Nat. Genet. 1999; 21: 220-224 https://doi.org/10.1038/6010
- Zervos AS, Gyuris J and Brent R. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites, Cell 1993; 72: 223-232 https://doi.org/10.1016/0092-8674(93)90662-A
- Zhang Z, Liong EC, Lau TY, Leung, KM, Fung PC and Tipoe GL. Induction of apoptosis by hexamehtylene bisacetamide is p53-dependent associated with telomerase activity but not with terminal differentiation, Int. J.Oncol. 2000; 16: 887-892